Dr. Jotte is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 N Williams St
Ste 100
Denver, CO 80218Phone+1 303-388-4876
Education & Training
- University of ColoradoFellowship, Hematology and Medical Oncology, 1998 - 2001
- University of ColoradoResidency, Internal Medicine, 1996 - 1998
- Vanderbilt University School of MedicineClass of 1996
Certifications & Licensure
- CO State Medical License 1998 - 2025
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 326 citationsAtezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III TrialRobert M. Jotte, Federico Cappuzzo, Ihor Vynnychenko, Daniil Stroyakovskiy, Delvys Rodriguez-Abreu
Journal of Thoracic Oncology. 2020-08-01 - 65 citationsClinical efficacy of atezolizumab plus bevacizumab and chemotherapy inmutated non-small cell lung cancer with,orcomutations: subgroup results from the phase III IMpowe...Howard Jack West, Mark McCleland, Federico Cappuzzo, Martin Reck, Tony Sk Mok
Journal for Immunotherapy of Cancer. 2022-02-01 - 135 citationsSafety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer, Including...David R. Spigel, Michael McCleod, Robert M. Jotte, Lawrence H. Einhorn, Leora Horn
Journal of Thoracic Oncology. 2019-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: